1. Home
  2. VSAT vs VERA Comparison

VSAT vs VERA Comparison

Compare VSAT & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ViaSat Inc.

VSAT

ViaSat Inc.

HOLD

Current Price

$34.38

Market Cap

4.6B

Sector

Technology

ML Signal

HOLD

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$50.80

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VSAT
VERA
Founded
1986
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
1.5B
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
VSAT
VERA
Price
$34.38
$50.80
Analyst Decision
Buy
Strong Buy
Analyst Count
7
11
Target Price
$33.00
$76.60
AVG Volume (30 Days)
1.5M
1.8M
Earning Date
02-05-2026
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,582,796,000.00
N/A
Revenue This Year
$5.08
N/A
Revenue Next Year
$3.47
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.23
N/A
52 Week Low
$7.36
$18.53
52 Week High
$43.59
$56.05

Technical Indicators

Market Signals
Indicator
VSAT
VERA
Relative Strength Index (RSI) 48.02 67.50
Support Level $33.72 $47.22
Resistance Level $37.46 $56.05
Average True Range (ATR) 1.85 2.51
MACD -0.02 -0.38
Stochastic Oscillator 35.08 55.88

Price Performance

Historical Comparison
VSAT
VERA

About VSAT ViaSat Inc.

Viasat Inc provides bandwidth technologies and services in three segments: communication services and defense and advanced technologies. The communication services segment provides a wide range of broadband and narrowband communications solutions across government and commercial mobility markets, as well as for residential and enterprise fixed broadband customers: and the defense and advanced technologies segment develops and offers a diverse array of resilient, vertically integrated solutions to government and commercial customers, leveraging core technical competencies in encryption, cyber security, tactical gateways, modems and waveforms. A large majority of the firm's revenue is generated from communication services segment.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: